New Jersey Resources Corporation (NJR) Bulls Seem To Be Pushing The Price Higher

New Jersey Resources Corporation (NJR) has seen some recent volatility in the market and its stock finished trading at $29.40 yesterday. People are starting to take interest of NJR as the stock traded as high as $29.42 and as low as $28.41 in the prior trading session.

New Jersey Resources Corporation (NJR) average trading volume is 486.57K. However, in the prior trading session New Jersey Resources Corporation (NJR) traded 391,418 shares. The 1st support level on NJR is $28.96 and the 1st resistance level on NJR is $37.27. NJR 50-day moving average is $28.12 and NJR 200-day moving average is $31.42.

New Jersey Resources Corporation (NJR) most recent performance has been indicated by the recent movement in NJR stock. NJR has performed 11.87% over the past 4 weeks, NJR has performed -6.70% over the past 3 months and NJR has shown -33.57% over the past year. New Jersey Resources Corporation (NJR) has a 52 week range of $21.14 to $45.76. New Jersey Resources Corporation (NJR) is trading 39.07% from its 52 week low and -35.75% from its 52 week high. New Jersey Resources Corporation (NJR) is displaying a 2.75% short float displaying the amount short in the float.

NJR has 95.76M shares outstanding and 95.10M shares in the float. New Jersey Resources Corporation (NJR) at this time has a market cap of $2.79B and income of 168.70M. The EPS next quarter for NJR is 0.57 and projected EPS next year is 12.54%. The market cap of New Jersey Resources Corporation (NJR) at $2.79B signifies how many People own shares of NJR and is based off the last price ($29.40) of NJR and the amount of shares outstanding (95.76M) with New Jersey Resources Corporation (NJR).

New Jersey Resources Corporation (NJR) has total cash (mrq) of 42.82M, total cash per share (mrq) of 0.45, total debt of NJR rests at 2.34B and total debt/equity (mrq) is 127.47. . New Jersey Resources Corporation (NJR) running cash flow (ttm) is 206.34M, NJR leveraged free cash flow (ttm) is -354.15M.

NJR is trading 5.16% above (bullish) its SMA20, 0.93% above (bullish) its SMA50 and -12.31% below (bearish) its SMA200.

Related Articles

Dada Group (NASDAQ: DADA) Extends Partnership With Lianhua Supermarket

Dada Group (NASDAQ: DADA) has disclosed that it has extended its strategic partnership with Lianhua Supermarket Holdings Co., Ltd. Both the companies aimed to focus...

Diana Shipping (NYSE: DSX) Signs Time Charter Contract With CLdN Cobelfret

Diana Shipping (NYSE: DSX) has revealed that it has signed a time charter contract with CLdN Cobelfret SA through its fully-owned unit. US$12,100 is...

Biogen (NASDAQ: BIIB) And Sage Therapeutics Inks Agreement To Develop Therapies For Depression

Biogen Inc. (NASDAQ: BIIB) and Sage Therapeutics, Inc. (NASDAQ: SAGE) communicated that they are partnering together and will be combining their efforts to develop...

Get in Touch

19,000FansLike
35,222FollowersFollow
22,458FollowersFollow

Latest Posts

Dada Group (NASDAQ: DADA) Extends Partnership With Lianhua Supermarket

Dada Group (NASDAQ: DADA) has disclosed that it has extended its strategic partnership with Lianhua Supermarket Holdings Co., Ltd. Both the companies aimed to focus...

Diana Shipping (NYSE: DSX) Signs Time Charter Contract With CLdN Cobelfret

Diana Shipping (NYSE: DSX) has revealed that it has signed a time charter contract with CLdN Cobelfret SA through its fully-owned unit. US$12,100 is...

Biogen (NASDAQ: BIIB) And Sage Therapeutics Inks Agreement To Develop Therapies For Depression

Biogen Inc. (NASDAQ: BIIB) and Sage Therapeutics, Inc. (NASDAQ: SAGE) communicated that they are partnering together and will be combining their efforts to develop...

BBVA And Sabadell Ends Talks Of A Merger Due To Conflict Over Price

Banco Bilbao Vizcaya Argentaria S.A. (NYSE: BBVA) and Banco de Sabadell SA have discussed the terms of a merger but the negotiation turned out...

Hancock Jaffe (NASDAQ: HJLI) Confirms 1:25 Reverse Stock Split

Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI), a company that manufactures medical devices used to treat heart problems, publicized that its Board of Directors has...